Print

Print


Researchers announce results of study on genetic variation in Parkinson's
disease
Researchers at the National Institutes of Health (NIH) have completed one of
the first large-scale studies of the role of common genetic variation in
Parkinson's disease (PD). While the results fill in some missing pieces of
the genetic puzzle, they are primarily of benefit as a starting point for
more detailed studies. The information generated by the study is now publicly
available in a database that will serve as a valuable research tool for the
future.
The study was led by researchers at the National Institute of Aging (NIA) and
National Institute of Neurological Disorders and Stroke (NINDS). The data
were derived from blood samples of 267 people with PD and 270 neurologically
normal individuals. These samples were made available by The NINDS Human
Genetics Resource Center at the Coriell Institute
(http://ccr.coriell.org/ninds), a publicly-funded bank for human cells, DNA
samples, clinical data, and other information that aims to accelerate
research on genetics of disorders of the nervous system. Results of the study
appear in the September 27, 2006, early online publication of The Lancet
Neurology.
"This is, to my knowledge, the first publicly available genotype data of this
magnitude outside of the International HapMap effort, and certainly the first
disease-linked dataset. I hope that this will prove to be a valuable resource
for future genetics work in Parkinson's disease, both for our laboratory and
for other researchers around the world," says Andrew Singleton, Ph.D., the
NIA researcher who led the study. "The use of neurologically normal controls
from the NINDS neurogenetics repository means that these data can be readily
used as a control group in future large scale SNP studies performed in many
other neurological diseases."
"The NINDS Human Genetics Resource Center has created a resource that allows
broad sharing and access to phenotypic and genotypic data, as well as
biological samples, with no restrictions. This approach to open, public
sharing of genetic materials and data is unprecedented. It will allow
scientific progress in the field of genetics to proceed in a much faster way,
and in ways we can't even currently anticipate," says Katrina Gwinn-Hardy,
M.D., the NINDS program contact for the Human Genetics Resource Center and an
author on the paper.
###
The NIA and the NINDS are components of the National Institutes of Health
(NIH) within the Department of Health and Human Services. The NIH -- The
Nation's Medical Research Agency -- includes 27 Institutes and Centers and is
a component of the U. S. Department of Health and Human Services. It is the
primary Federal agency for conducting and supporting basic, clinical, and
translational medical research, and it investigates the causes, treatments,
and cures for both common and rare diseases. For more information about NIH
and its programs, visit http://www.nih.gov.

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn